Interim dividend of Rs 7 and proposed 1:1 bonus issue

Corporate Actions View source PDF Explain this filing

LALPATHLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.6%Reaction day

₹1545.00

prior close

₹1540.80

announcement price

In-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-0.6%+2.2% vs market

Healthcare Service Provider peers, median of 22sector+0.0%+1.6% vs sector

On the reaction day the stock moved 2.2 pts more than Nifty Smallcap 250 and 1.6 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

+2.5

15m

+2.1

30m

+3.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.6-0.6+2.2+0.0+1.6

Next day

+5.1+0.1+5.0+0.0+5.1

+2.4-0.5+3.0+0.0+2.4

+0.8-2.0+2.8-2.3+3.1

+0.3-2.2+2.5-3.0+3.3

-0.2-2.3+2.0-0.4+0.2

-0.2-1.7+1.5-0.2+0.1

15d

+0.9-4.6+5.5-1.6+2.6

-1.0-3.7+2.7-5.8+4.8

-4.0-4.2+0.2-7.2+3.2

-7.8-10.9+3.2-14.2+6.4

UpDownMarket · Nifty Smallcap 250Sector · Healthcare Service Provider peers, median of 22Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Dr. Lal Path Labs approved Q2 and H1 FY26 unaudited results and declared a second interim dividend of INR 7 per share. The record date is November 7, 2025, with payment within 30 days. The board proposed a 1:1 bonus issue of about 8.38 crore shares, subject to shareholder approval; its record date is yet to be set. It also plans to raise authorized capital to INR 200 crore and introduced an employee RSU plan for up to 527,403 shares.

Likely market impact

The dividend and proposed 1:1 bonus may support sentiment, but the bonus needs approval and does not itself add value per share.